Thrombosis screening with PCR is a molecular genetic diagnostic test used by healthcare professionals to detect genetic mutations predisposing to thrombophilia, aggravating abnormal blood clotting within blood vessels and obstructing blood flow. This test is recommended for evaluating thrombophilia risk with venous thromboembolism, thrombosis, organ infarction and recurrent miscarriages. This test helps initiate thromboprophylaxis strategies, genetic risk assessment, and prevention of thrombotic events.
This test can detect 4 mutations F5 c.1601G>A (Factor V Leiden), F2 c.*97G>A [Factor II (prothrombin) G20210A]
MTHFR c.655C>T [MTHFR (methylene tetrahydrofolate reductase)] and MTHFR c.1286A>C